| Financial Year |
March 31 2023 |
| Monetary Funds |
435,724,339.27 |
| Held-for-trading Financial Assets |
105,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
20,035,136.06 |
| Advances to Suppliers |
39,127,986.35 |
| Other Receivables |
4,187,689.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
93,493.15 |
| Dividend Receivable |
-- |
| Inventories |
1,227,729,683.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,120,309.59 |
| Total Current Assets |
1,839,925,143.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,162,921.04 |
| Investment Properties |
58,468,769.56 |
| Fixed Assetes |
1,067,486,469.50 |
| Under-construction Projects |
11,916,977.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
17,409,115.44 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
150,815,092.17 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
32,726,756.13 |
| Deferred Income Tax Assets |
20,769,099.71 |
| Other Non-Current Assets |
2,574,080.15 |
| Sub-Total of Non-Current Assets |
1,388,085,373.84 |
| Total Assets |
3,228,010,517.65 |
| Short-Term Loans |
100,049,862.64 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
82,855,446.49 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,727,608.14 |
| Taxes Payable |
42,638,532.25 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
51,463,019.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,052,495.22 |
| Other Current Liabilities |
7,231,636.18 |
| Sub-Total of Current Liabilities |
364,682,197.23 |
| Long-term Loans |
9,248,861.54 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
49,956,028.25 |
| Total Liabilities |
414,638,225.48 |
| Paid-In Capital(Or Share Stock) |
472,562,974.00 |
| Capital Surplus |
1,238,713,015.39 |
| Surplus Reserve |
166,228,606.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
957,633,234.73 |
| Minority Stockholder's Interest |
-22,050,746.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,835,423,039.06 |
| Owner's Equity（Stockholder's Equity） |
2,813,372,292.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,228,010,517.65 |
